Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williams, G.
Right arrow Articles by Bloom, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, G.
Right arrow Articles by Bloom, S. R.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 37, Issue 6 763-772, Copyright © 1988 by American Diabetes Association


ARTICLES

Increased hypothalamic neuropeptide Y concentrations in diabetic rat

G Williams, JH Steel, H Cardoso, MA Ghatei, YC Lee, JS Gill, JM Burrin, JM Polak and SR Bloom
Francis Fraser Laboratories, Department of Medicine, Royal Postgraduate Medical School, London, United Kingdom.

Central and lateral hypothalamic concentrations of 10 regulatory peptides were measured by radioimmunoassay in streptozocin-induced diabetic (STZ-D) and matched control rats between 1 day and 14 wk after diabetes induction. After 2 wk, both central and lateral hypothalamic neuropeptide Y (NPY) concentrations in STZ-D rats were consistently higher than those found in control rats, with significant 30-50% increases at 4 wk in the central hypothalamus, and at 6 and 14 wk in both central and lateral hypothalamus. Immunocytochemical studies in 4- and 6-wk STZ-D animals showed the appearance of intensely NPY-positive swollen cell bodies in the supraoptic nucleus and a subjective increase in NPY staining of medial hypothalamic nerve fibers. Central hypothalamic concentrations of three other peptides were significantly greater in STZ-D animals than those in control animals at single points (neurotensin, 1 day; calcitonin gene-related peptide, 2 wk; neurokinin, 4 wk). Hypothalamic concentrations of the other six peptides examined (bombesin, galanin, neuromedin B, substance P, somatostatin, and vasoactive intestinal peptide) did not differ significantly between STZ-D and control groups at any time. However, galanin immunostaining in the supraoptic and magnocellular paraventricular nuclei was strikingly concentrated in a reduced number of distended cell bodies. Hypothalamic peptide changes in STZ-D could be related to metabolic disturbance, changes in energy and water balance, altered pituitary function, or other factors. Persistently elevated concentrations of NPY, a very potent central stimulant of eating and drinking, may mediate the hyperphagia and polydipsia characteristic of STZ-D.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
D. Porte Jr.
Central Regulation of Energy Homeostasis: The Key Role of Insulin
Diabetes, December 1, 2006; 55(Supplement_2): S155 - S160.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. Namkoong, M. S. Kim, P. G. Jang, S. M. Han, H. S. Park, E. H. Koh, W. J. Lee, J. Y. Kim, I. S. Park, J. Y. Park, et al.
Enhanced Hypothalamic AMP-Activated Protein Kinase Activity Contributes to Hyperphagia in Diabetic Rats
Diabetes, January 1, 2005; 54(1): 63 - 68.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
R G P Denis, C Bing, S Brocklehurst, J A Harrold, R G Vernon, and G Williams
Diurnal changes in hypothalamic neuropeptide and SOCS-3 expression: effects of lactation and relationship with serum leptin and food intake
J. Endocrinol., October 1, 2004; 183(1): 173 - 181.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. F. Turi, Z. Liposits, S. M. Moenter, C. Fekete, and E. Hrabovszky
Origin of Neuropeptide Y-Containing Afferents to Gonadotropin-Releasing Hormone Neurons in Male Mice
Endocrinology, November 1, 2003; 144(11): 4967 - 4974.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
X. J. Cai, M. L. Evans, C. A. Lister, R. A. Leslie, J. R. S. Arch, S. Wilson, and G. Williams
Hypoglycemia Activates Orexin Neurons and Selectively Increases Hypothalamic Orexin-B Levels: Responses Inhibited by Feeding and Possibly Mediated by the Nucleus of the Solitary Tract
Diabetes, January 1, 2001; 50(1): 105 - 112.
[Abstract] [Full Text]


Home page
Pharmacol. Rev.Home page
A. Inui
Transgenic Approach to the Study of Body Weight Regulation
Pharmacol. Rev., March 1, 2000; 52(1): 35 - 62.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. D. Raposinho, P. Broqua, D. D. Pierroz, A. Hayward, Y. Dumont, R. Quirion, J.-L. Junien, and M. L. Aubert
Evidence That the Inhibition of Luteinizing Hormone Secretion Exerted by Central Administration of Neuropeptide Y (NPY) in the Rat Is Predominantly Mediated by the NPY-Y5 Receptor Subtype
Endocrinology, September 1, 1999; 140(9): 4046 - 4055.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
B. Xu, P. S. Kalra, W. G. Farmerie, and S. P. Kalra
Daily Changes in Hypothalamic Gene Expression of Neuropeptide Y, Galanin, Proopiomelanocortin, and Adipocyte Leptin Gene Expression and Secretion: Effects of Food Restriction
Endocrinology, June 1, 1999; 140(6): 2868 - 2875.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
S. P. Kalra, M. G. Dube, S. Pu, B. Xu, T. L. Horvath, and P. S. Kalra
Interacting Appetite-Regulating Pathways in the Hypothalamic Regulation of Body Weight
Endocr. Rev., February 1, 1999; 20(1): 68 - 100.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. Bing, H. M. Frankish, L. Pickavance, Q. Wang, D. F. C. Hopkins, M. J. Stock, and G. Williams
Hyperphagia in cold-exposed rats is accompanied by decreased plasma leptin but unchanged hypothalamic NPY
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 1998; 274(1): R62 - R68.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1988 by the American Diabetes Association.